The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Francesco Caponigro

National Tumor Institute

Naples

Italy

[email]@libero.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • National Tumor Institute, Naples, Italy. 2004 - 2010
  • Istituto Nazionale Tumori, Fondazione G. Pascale, Via Mariano Semmola 80131, Napoli, Italy. 2009
  • Medical Oncology B, National Tumour Institute of Naples Fondazione G. Pascale Via M. Semmola, Naples, Italy. 2003 - 2009

References

  1. Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors. Caponigro, F., Lorusso, D., Fornari, G., Barone, C., Merlano, M., Airoldi, M., Schena, M., MacArthur, R., Weitman, S., Jannuzzo, M.G., Crippa, S., Fiorentini, F., Petroccione, A., Comis, S. Cancer Chemother. Pharmacol. (2010) [Pubmed]
  2. Treatment approaches to nasopharyngeal carcinoma: a review. Caponigro, F., Longo, F., Ionna, F., Perri, F. Anticancer. Drugs (2010) [Pubmed]
  3. Docetaxel in the management of head and neck cancer. Caponigro, F., Longo, F., Perri, F., Ionna, F. Anticancer. Drugs (2009) [Pubmed]
  4. An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer. Caponigro, F., Lacombe, D., Twelves, C., Bauer, J., Govaerts, A.S., Marréaud, S., Milano, A., Anthoney, A. Eur. J. Cancer (2009) [Pubmed]
  5. A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. Caponigro, F., Romano, C., Milano, A., Solla, R., Franchin, G., Adamo, V., Mari, E., Morrica, B., Pepe, S. Anticancer. Drugs (2008) [Pubmed]
  6. Phase II study of rubitecan in recurrent or metastatic head and neck cancer. Caponigro, F., Cartenì, G., Droz, J.P., Milano, A., Davis, W.B., Pollard, P. Cancer Chemother. Pharmacol. (2008) [Pubmed]
  7. Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents. Caponigro, F., Milano, A., Basile, M., Ionna, F., Iaffaioli, R.V. Curr. Opin. Oncol (2006) [Pubmed]
  8. Epidermal growth factor receptor as a major anticancer drug target. Caponigro, F., Milano, A., Ottaiano, A., Iaffaioli, R.V. Expert Opin. Ther. Targets (2006) [Pubmed]
  9. A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer. Caponigro, F., Willemse, P., Sorio, R., Floquet, A., van Belle, S., Demol, J., Tambaro, R., Comandini, A., Capriati, A., Adank, S., Wanders, J. Invest. New. Drugs (2005) [Pubmed]
  10. New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004. Caponigro, F., Basile, M., de Rosa, V., Normanno, N. Anticancer. Drugs (2005) [Pubmed]
  11. Monoclonal antibodies targeting epidermal growth factor receptor and vascular endothelial growth factor with a focus on head and neck tumors. Caponigro, F., Formato, R., Caraglia, M., Normanno, N., Iaffaioli, R.V. Curr. Opin. Oncol (2005) [Pubmed]
  12. Gastric cancer. Treatment of advanced disease and new drugs. Caponigro, F., Facchini, G., Nasti, G., Iaffaioli, R.V. Front. Biosci. (2005) [Pubmed]
  13. Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer. Caponigro, F. Anticancer. Drugs (2004) [Pubmed]
  14. New cytotoxic and molecular-targeted therapies of head and neck tumors. Caponigro, F., Ionna, F., Comella, G. Curr. Opin. Oncol (2004) [Pubmed]
  15. Farnesyl transferase inhibitors in clinical development. Caponigro, F., Casale, M., Bryce, J. Expert. Opin. Investig. Drugs (2003) [Pubmed]
 
WikiGenes - Universities